Status:
COMPLETED
Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Vaccines, Pneumococcal Conjugate Vaccine
Eligibility:
All Genders
65+ years
Phase:
PHASE2
Brief Summary
There is evidence that aluminum phosphate (AlPO4) contained as an adjuvant in conjugate vaccines enhances the immune response in infants. There is no data so far evaluating whether this also applies t...
Eligibility Criteria
Inclusion
- Male and female adults 65 years of age and older.
- Determined by medical history, physical examination, and clinical judgment to be eligible for the study.
- Expected to be available for the duration of the trial (up to approximately 13 months).
Exclusion
- Received previous immunization with 23vPS.
- Serious chronic disorders including metastatic malignancy
- Known or suspected hypersensitivity to any vaccine or vaccine components
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2007
Estimated Enrollment :
915 Patients enrolled
Trial Details
Trial ID
NCT00269672
Start Date
September 1 2005
End Date
February 1 2007
Last Update
August 5 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.